Remove 2018 Remove Adverse Reactions Remove Labelling
article thumbnail

FDA Releases Draft Labeling Guidance for Biosimilar Products

Big Molecule Watch

Last week, FDA released a draft guidance, “ Labeling for Biosimilar and Interchangeable Biosimilar Products ” (“2023 Draft Guidance”) that—when finalized—will revise and replace its July 2018 final guidance, “ Labeling for Biosimilar Products.”

article thumbnail

Teething

RX Note

Laboratory analysis of some homeopathic remedies found greater amounts of Atropa belladonna (deadly nightshade, an anticholinergic agent) than claimed on the label. Viscous lidocaine has been associated with serious adverse reactions ( including death ) in young children being treated for mouth pain, including teething.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies

pharmaphorum

The combination therapies had previously been marketed following accelerated approval in November 2018 on the basis of early stage results. The drug’s US label also covers certain patients with chronic lymphocytic leukaemia, including a chemotherapy-free regimen for previously untreated patients. months compared with 4.1

article thumbnail

Drugs and Pregnancy

RX Note

FDA Pregnancy and Lactation Labelling Final Rule, 2015 In the past, FDA Pregnancy Categories was used in US. To address this, on 13 December 2014, the FDA published the Pregnancy and Lactation Labelling Rule” (PLLR). Labelling for prescription drugs approved on or after June 30, 2001, will be phased in gradually.

article thumbnail

FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI

LifeProNow

These sNDAs are supported by results from the PHAROS trial ( NCT03915951 ), an open-label, multicenter, non-randomized, Phase 2 study (n=98) to determine the safety, tolerability, and efficacy of BRAFTOVI given in combination with MEKTOVI in patients with BRAF V600E-mutant metastatic NSCLC. of patients.

article thumbnail

World Standards Day: Recognizing How Standards Enable a Strong Medicines Supply Chain

Quality Matters

There are also related standards that address a wide range of topics such as packaging, storage and distribution of medicines, the preparation of compounded medicines and prescription labeling. This is what has been happening with nitrosamine impurities.

article thumbnail

Selenium: The Nutrient That Can Reduce Thyroid Antibodies by 40%

The Thyroid Pharmacist

As of 2018, there have been at least two active studies underway to gain more definitive results, the GRASS (Graves’ Disease Selenium Supplementation) and the CATALYST (The Chronic Autoimmune Thyroiditis Quality of Life Selenium Trial). Published 2018 Sep 26. doi:10.1155/2018/3763565. 2018 Jul 30. 2018 Jul 30.

Dosage 59